Li, Y.; Feng, L.; Xie, D.; Lin, M.; Li, Y.; Chen, N.; Yang, D.; Gao, J.; Zhu, Y.; Gong, Q.
Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway. Antioxidants 2022, 11, 1465.
https://doi.org/10.3390/antiox11081465
AMA Style
Li Y, Feng L, Xie D, Lin M, Li Y, Chen N, Yang D, Gao J, Zhu Y, Gong Q.
Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway. Antioxidants. 2022; 11(8):1465.
https://doi.org/10.3390/antiox11081465
Chicago/Turabian Style
Li, Yeli, Linying Feng, Dianyou Xie, Mu Lin, Yiqi Li, Nana Chen, Danli Yang, Jianmei Gao, Yizhun Zhu, and Qihai Gong.
2022. "Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway" Antioxidants 11, no. 8: 1465.
https://doi.org/10.3390/antiox11081465
APA Style
Li, Y., Feng, L., Xie, D., Lin, M., Li, Y., Chen, N., Yang, D., Gao, J., Zhu, Y., & Gong, Q.
(2022). Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway. Antioxidants, 11(8), 1465.
https://doi.org/10.3390/antiox11081465
